GGrantIndex
← Leaderboards

University Of Alberta

Edmonton, AB

Compare ↔
$40,233,514
Total funding
37
Grants

Funding over time

peak $4.3M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$40,233,514 · 37

By mechanism

R01$22,760,237 · 20
U01$11,794,925 · 3
R37$2,420,269 · 1
R21$2,340,395 · 8
U10$507,142 · 1
R33$166,706 · 1

Investigators at University Of Alberta

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Stephanie Yanow$1,943,9221 gr2Cindy Im$1,630,7433 gr3Patrick Macdonald$1,016,8662 gr4Roger J Zemp$621,0002 gr5Yan Yuan$139,5341 gr

All-Time

Most funded here, all years

1Norman J Dovichi$12,646,39214 gr2Stephen L Archer$5,180,9303 gr3David James Bennett$3,383,2632 gr4Douglas L Wahlsten$2,490,7131 gr5Andrew M Shapiro$2,142,3662 gr6Vivian K. Mushahwar$2,032,6881 gr7Stephanie Yanow$1,943,9221 gr8Cindy Im$1,630,7433 gr

Largest grants

Islet Transplant - Costimulatory Blockade with LEA29Y$2,900,000
U01 · FY2004 · AI
Islet Transplant - Costimulatory Blockade with LEA29Y$2,660,000
U01 · FY2005 · AI
Islet Transplant - Costimulatory Blockade with LEA29Y$1,855,350
U01 · FY2006 · AI
Linking islet cell function and identity from in vitro to in situ$776,917
U01 · FY2018 · DK
Linking islet cell function and identity from in vitro to in situ$762,368
U01 · FY2019 · DK
Linking islet cell function and identity from in vitro to in situ$753,464
U01 · FY2020 · DK
Linking islet cell function and identity from in vitro to in situ$744,534
U01 · FY2021 · DK
TRIAL OF ANTI-TNF ALPHA IN ISLET TRANSPLANTATION$568,520
R01 · FY2002 · DK
TRIAL OF ANTI-TNF ALPHA IN ISLET TRANSPLANTATION$551,961
R01 · FY2001 · DK
TRIAL OF ANTI-TNF ALPHA IN ISLET TRANSPLANTATION$535,885
R01 · FY2000 · DK
Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria.$491,792
R01 · FY2021 · AI
Exploiting cross-reactive, conserved epitopes in Plasmodium vivax to develop a vaccine against falciparum placental malaria.$490,848
R01 · FY2020 · AI
Mechanisms of Islet Failure in CF$437,156
R01 · FY2024 · DK
Impact of Exercise on Sarcopenia$436,995
R01 · FY2010 · AG
Mechanisms of Islet Failure in CF$433,625
R01 · FY2025 · DK
Impact of Exercise on Sarcopenia$433,094
R01 · FY2009 · AG
Impact of Exercise on Sarcopenia$419,380
R01 · FY2011 · AG
Longitudinal Study of Cognitive Aging$396,396
R01 · FY2014 · AG
Impact of Exercise on Sarcopenia$394,861
R01 · FY2012 · AG
PERIPHERAL NEUROPATHY IN LENTIVIRUS INFECTIONS: EARLY VIRAL AND HOST DETERMINANTS$391,925
R01 · FY2010 · NS